Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.

Sue A BrownGregory P ForlenzaBruce W BodeJordan E Pinsker Carol J LevyAmy B CriegoDavid W HansenIrl B HirschAnders L CarlsonRichard M Bergenstal Jennifer L Sherr Sanjeev N Mehta Lori M B Laffel Viral N ShahAnuj BhargavaTracey D BrownSarah A MacLeishDaniel J DeSalvoThomas C JonesGrazia AleppoBruce A BuckinghamTrang T Lynull null

Published in: Diabetes care (2021)

This tubeless automated insulin delivery system was safe and allowed participants to significantly improve HbA1c levels and time in target glucose range with a very low occurrence of hypoglycemia.

Keyphrases

type diabetes
glycemic control
blood glucose
deep learning
machine learning
high throughput
risk assessment
phase iii
insulin resistance
study protocol
clinical trial
weight loss
childhood cancer
double blind
metabolic syndrome
blood pressure
randomized controlled trial
young adults
skeletal muscle